PMC:7195088 / 74334-74919
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2046 | 542-550 | Species | denotes | patients | Tax:9606 |
2051 | 103-111 | Disease | denotes | COVID-19 | MESH:C000657245 |
2052 | 533-541 | Disease | denotes | COVID-19 | MESH:C000657245 |
2072 | 292-300 | Species | denotes | patients | Tax:9606 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T398 | 103-111 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T399 | 533-541 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T396 | 9-14 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | label |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T125 | 9-14 | Chemical | denotes | label | http://purl.obolibrary.org/obo/CHEBI_35209 |
T27070 | 15-24 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T16804 | 29-52 | Chemical | denotes | anti-inflammatory drugs | http://purl.obolibrary.org/obo/CHEBI_35472 |
T98752 | 47-52 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T504 | 0-121 | Sentence | denotes | Many off-label antiviral and anti-inflammatory drugs are being administered in this first phase of the COVID-19 pandemic. |
T505 | 122-383 | Sentence | denotes | While we do not discourage their use, physicians must be aware that because of the lack of high-level evidence, they may be ethically justifiable only in those worsening patients unlikely to improve with only supportive care and who cannot be enrolled onto RCT. |
T506 | 384-585 | Sentence | denotes | Implementation of well-designed RCT should be expanded as much as possible, as RCTs are the most secure way to change for the better our approach to COVID-19 patients, including our frontline opinions. |